Continuous administration of the somatostatin structural derivative /TT-232/ by subcutaneously implanted osmotic pump improves the efficacy and potency of antitumor therapy in different mouse and human tumor models.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples